We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
-2.87%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.4B
AUM Growth
-$4.5B
(-6.3%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,643
New
69
Increased
632
Reduced
516
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$156M |
| 2 |
Amazon
AMZN
|
+$104M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$79.1M |
| 4 |
Eversource Energy
ES
|
+$73.2M |
| 5 |
Exelon
EXC
|
+$67.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$159M |
| 2 |
Meta Platforms (Facebook)
META
|
+$120M |
| 3 |
Avantor
AVTR
|
+$108M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$99.1M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.43% |
| 2 | Healthcare | 16.31% |
| 3 | Industrials | 15.57% |
| 4 | Utilities | 11.18% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Conagra Brands
CAG
$7.34B
| $36.4M | 0.05% |
1,114,134
+20,799
| +2% | +$714K |
|
327
Aon
AON
$74.5B
| $36.2M | 0.05% |
134,984
-6,862
| -5% | -$1.94M |
|
328
Cognizant
CTSH
$26.1B
| $35.3M | 0.05% |
615,336
+6,385
| +1% | +$418K |
|
329
Equity Residential
EQR
$24.8B
| $35.3M | 0.05% |
525,483
+5,137
| +1% | +$380K |
|
|
CNH
330
CNH Industrial
CNH
$16.6B
| $35.1M | 0.05% |
3,083,856
+326,394
| +12% | +$3.93M |
|
331
Stride
LRN
$3.37B
| $34.9M | 0.05% |
829,192
-28,291
| -3% | -$1.14M |
|
332
NIO
NIO
$11.3B
| $34.7M | 0.05% |
2,202,299
+32,823
| +2% | +$650K |
|
333
Caribou Biosciences
CRBU
$165M
| $34.7M | 0.05% |
3,290,898
+601,671
| +22% | +$5.61M |
|
334
TJX Companies
TJX
$168B
| $34.5M | 0.05% |
554,896
-4,229
| -0.8% | -$266K |
|
335
First American
FAF
$7.47B
| $34.1M | 0.05% |
738,329
-12,170
| -2% | -$658K |
|
336
Target
TGT
$70.3B
| $33.9M | 0.05% |
228,761
-16,396
| -7% | -$2.63M |
|
337
Citigroup
C
$232B
| $33.4M | 0.05% |
802,575
-17,825
| -2% | -$881K |
|
338
TE Connectivity
TEL
$62.4B
| $33.3M | 0.05% |
301,533
+17,901
| +6% | +$2.23M |
|
339
Shell
SHEL
$247B
| $33.3M | 0.05% |
668,494
+508,257
| +317% | +$26.2M |
|
340
EOG Resources
EOG
$74.6B
| $33M | 0.05% |
294,920
+1,058
| +0.4% | +$119K |
|
341
Progressive
PGR
$121B
| $32.2M | 0.05% |
276,891
+1,126
| +0.4% | +$136K |
|
342
SBA Communications
SBAC
$19.6B
| $32M | 0.05% |
112,273
+5,415
| +5% | +$1.76M |
|
343
Builders FirstSource
BLDR
$7.97B
| $31.9M | 0.05% |
541,516
+126,511
| +30% | +$7.91M |
|
|
SWTX
344
DELISTED
SpringWorks Therapeutics
SWTX
| $31.5M | 0.05% |
1,105,540
+1,963
| +0.2% | +$56.3K |
|
345
Mondelez International
MDLZ
$80.6B
| $31.4M | 0.05% |
572,487
+1,238
| +0.2% | +$76.9K |
|
346
Yum China
YUMC
$16.3B
| $31.3M | 0.05% |
660,686
+6,200
| +0.9% | +$298K |
|
347
Elanco Animal Health
ELAN
$11.3B
| $30.9M | 0.05% |
2,488,180
+52,998
| +2% | +$926K |
|
348
Denali Therapeutics
DNLI
$4.06B
| $30.8M | 0.05% |
1,003,185
-11,973
| -1% | -$389K |
|
349
Arcutis Biotherapeutics
ARQT
$3.29B
| $30.6M | 0.05% |
1,602,786
+679,892
| +74% | +$15.4M |
|
350
Altria Group
MO
$110B
| $30.3M | 0.04% |
749,928
+2,330
| +0.3% | +$102K |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q3 2022 Portfolio in Review
As of Q3 2022, Pictet Asset Management (Switzerland) held 1,643 positions worth $67.4B, down 6.3% from $71.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pictet Asset Management (Switzerland)'s Q3 2022 filing shows 69 new, 632 increased, 516 reduced and 78 closed positions. Its largest new stake was Ventyx Biosciences: 1,071,983 shares worth $37.4M. The largest sale was ZENDESK INC, an estimated $159M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q3 2022 buy was Ventyx Biosciences: 1,071,983 shares worth $37.4M.
- Pictet Asset Management (Switzerland) added most to Weyerhaeuser in Q3 2022, an estimated $156M increase.
- Pictet Asset Management (Switzerland)'s biggest Q3 2022 reduction was ZENDESK INC, cutting an estimated $159M.
- Pictet Asset Management (Switzerland) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $32M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 15% of its $67.4B portfolio in Q3 2022.
- Pictet Asset Management (Switzerland) opened 69 new positions and closed 78 in Q3 2022.
- Pictet Asset Management (Switzerland)'s portfolio value fell 6.3% quarter-over-quarter to $67.4B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.